[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"macular-edema-me\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:macular-edema-me":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,74],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100632901","video-intervention-to-improve-understanding-of-diabetic-retinopathy-at-zuckerberg-san-francisco-general-hospital-and-trauma-center-100632901",false,"NCT07519707","Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center","Addressing Low Patient Follow-up Rates Among Patients With Diabetes in the Eye Clinic at Zuckerberg San Francisco General Hospital and Trauma Center","Inclusion Criteria:\n\n* Diagnosis of diabetes mellitus with or without diabetic retinopathy\n* Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care\n* Able to speak and understand English or Spanish\n\nExclusion Criteria:\n\n* Unable to view or understand the videos due to significant vision obstruction or impairment","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.",[26,27],"Diabetic Retinopathy (DR)","Macular Edema (ME)",[29,30,31,32,33],"diabetic retinopathy","diabetes","ophthalmology","vision","health literacy","RECRUITING","2026-04-06",{"date":37,"type":38},"2026-04-09","ACTUAL",{"date":40,"type":20},"2026-05",{"date":42,"type":20},"2027-12",{"name":44,"class":45},"University of California, San Francisco","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":46},"100604091","early-phase-1-suprachoroidal-triamcinolone-in-macular-edema-for-patients-with-non-infectious-uveitis-resistant-to-subtenon-triamcinolon-100604091","NCT07145008","Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon","Inclusion Criteria:\n\n* Non-infectious uveitis complicated with macular edema\n* Uveitic macular edema of less than four months' duration\n* Macular edema persisted despite lack of intra-ocular inflammation\n* No response to posterior sub-Tenon triamcinolone acetonide injections\n\nExclusion Criteria:\n\n* Those with epiretinal membrane-associated macular edema\n* Below 18 years",{"count":54,"type":20},20,[56],"EARLY_PHASE1","The goal of this study is to learn if a suprachoroidal triamcinolone injection can treat vision-threatening swelling in the center of the retina (macular edema) caused by non-infectious uveitis, especially in people who did not improve after a standard steroid injection around the eye (sub-Tenon injection).\n\nThe main questions it aims to answer are:\n\nDoes vision improve on the eye chart after the injection?\n\nDoes the injection lower retinal swelling (reduction in thickness) within 3 months?\n\nParticipants will:\n\nHave a pre-treatment check (vision test, slit-lamp exam, and a retinal scan called OCT).\n\nReceive one suprachoroidal triamcinolone injection under anesthetics drops in a sterile setting (operating room) with standard monitoring.\n\nReturn for visits about 1 month and 3 months after treatment for repeat vision tests, and OCT scans.\n\nContact the clinic if they notice pain, redness, new floaters, or worsening vision.",[27,59],"Non Infectious Uveitis",[61,62,63,64],"Suprachoroidal Triamcinolone","Macular Edema","Non infectious uveitis","Subtenon resistant","2025-08-21",{"date":67,"type":38},"2025-08-28",{"date":69,"type":38},"2024-09-01",{"date":71,"type":20},"2026-12-01",{"name":73,"class":45},"University of Baghdad",{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":21,"phases":84,"briefSummary":85,"conditions":86,"keywords":89,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":46},"100594473","minimal-vitrectomy-surgery-for-epiretinal-membrane-100594473","NCT07019896","Minimal Vitrectomy Surgery for Epiretinal Membrane","Minimal Vitrectomy Surgery (MVS) Versus Conventional Vitrectomy for the Treatment of Idiopathic Epiretinal Membrane: A Multicenter Randomized Controlled Trial","MVS-ERM","Inclusion Criteria:\n\n1. Age ≥ 18 years.\n2. Diagnosis of idiopathic epiretinal membrane (ERM) confirmed by clinical examination and OCT imaging.\n3. Clear ocular media allowing adequate fundus imaging.\n4. Phakic eye.\n5. Ability and willingness to provide written informed consent.\n\nExclusion Criteria:\n\n1. Prior cataract surgery or advanced cataract requiring combined surgery. Co-existing retinal diseases (e.g., diabetic retinopathy, retinal detachment, retinal vein occlusion).\n2. Systemic conditions preventing safe surgery or follow-up.\n3. History of prior ocular or periocular corticosteroid use, including intraocular injection, periocular injection, or long-term topical corticosteroid eye drops.",{"count":83,"type":20},140,[23],"This multicenter randomized controlled trial evaluates Minimal Vitrectomy Surgery (MVS) versus conventional vitrectomy for idiopathic epiretinal membrane (ERM). The primary endpoints include visual acuity improvement and cataract progression after 12 months. MVS aims to minimize vitreous removal while ensuring complete membrane removal through adaptive limited vitrectomy.",[87,27,88],"Epiretinal Membrane","Nuclear Cataract",[90,91,92,93],"Idiopathic Epiretinal Membrane (ERM)","Minimal Vitrectomy Surgery (MVS)","Nonvitrectomizing Vitreous Surgery (NVS)","pars plana Vitrectomy (PPV)","2025-06-05",{"date":96,"type":38},"2025-06-13",{"date":98,"type":38},"2024-12-01",{"date":100,"type":20},"2026-11-30",{"name":102,"class":45},"Peking Union Medical College Hospital"]